TLDR:
- XGen Venture, an Italian life sciences investor, has raised €160 million for its debut fund.
- The fund is anchored by Micheli Associati, along with EIF and CDP VC, and includes other LPs such as UniCredit, Quaestio Capital, Banco BPM, Inarcassa, ENPAM, Fondazione di Sardegna, and Banca Sella Holding.
An Italian life sciences investor, XGen Venture, has successfully raised €160 million for its debut fund. The fund is anchored by Micheli Associati, which is the majority shareholder of Genextra, and includes contributions from EIF and CDP VC. Other notable LPs involved in the fund include UniCredit, Quaestio Capital, Banco BPM, Inarcassa, ENPAM, Fondazione di Sardegna, and Banca Sella Holding.
